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Imprinted nanoparticles were prepared by the inverse microemulsion polymerization method. A fraction
of Lpp20, an outer membrane protein of H. pylori known as NQA, was chosen as template and modiﬁed
with myristic acid to facilitate its localization on the surface of the nanoparticles. The interaction between
these SMINs with the template NQA were evaluated using surface plasmon resonance (SPR), change in
zeta potential and ﬂuorescence polarization (FP). The results were highly consistent in demonstrating a
preferential recognition of the template NQA for SMINs compared with the control nanoparticles. In vitro
experiments also indicate that such SMINs are able to adhere to H. pylori and may be useful for H. pylori
eradication.
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During recent decades, mucoadhesive drug delivery systems
(MDDS) for Helicobacter pylori (H. pylori) eradication have been
frequently reported. The ability of MDDS to adhere to the mucus
layer prolongs their retention time in the gastrointestinal tract and
thereby enables the loaded drug to interact with H. pylori for a
longer time. However, this non-speciﬁc adhesion is affected not
only by varying turnover time and composition of mucus but also
by how the mucoadhesive polymer used to make MDDS responds
to changes in pH and physiological or disease conditions. Such
variability seriously limits the application of this technique1. This
paper reports the results of an investigation into the preparation
and characterization of surface molecularly imprinted nanoparti-
cles (SMINs) designed to bind to H. pylori.
Molecular imprinting involves the synthesis of polymers in the
presence of a template molecule. The process produces polymers
with surface binding sites that complement those of the template in
terms of its size, shape and functional group orientation2.
Molecularly imprinted polymers (MIPs) have been widely recog-
nized as promising alternatives to enzymes, antibodies and natural
receptors due to their speciﬁcity, robustness and reusability3.
However, most of the successful examples are imprinted with
low molecular weight compounds while imprinting with larger
molecules such as peptides and proteins, or with complex systems
such as viruses and cells is still in its infancy. According to
Kryscio et al.4, it is now evident that the general design principles
of low molecular weight MIPs do not apply to the macromolecular
regime. The monomers commonly employed in MIPs signiﬁcantly
alter the template conformation prior to polymerization and
compromise the speciﬁc recognition of the template.
Three main approaches have been developed for protein
imprinting2: (1) Bulk imprinting where the protein template is
wholly imprinted in the bulk of the polymer matrix and is bound
as a whole molecule by functional monomers; (2) surface imprint-
ing where the protein template is partially imprinted in the bulk of
the polymer matrix and binding sites are at or close to the surface;
and (3) epitope imprinting where only a small part of the protein is
imprinted but the resulting MIPs are able to recognize the whole
protein. In bulk imprinting, the binding sites of the template
proteins tend to be restricted within the polymer matrix and are
only exposed by grinding the matrix. As a result, surface and
epitope imprinting have attracted increasing interest.
To mimic the genuine “antigen-antibody” interaction, it is
important that well-designed imprints are evenly distributed on
the surface of SMINs. To achieve this goal, Zeng et al.5 initiated a
so-called “general strategy for surface imprinting” in which a
hydrophilic peptide could be located at the surface of nanoparticles
after modiﬁcation. We have used this approach in preparing
SMINs.
Lpp20 is a conserved 20 kDa outer membrane lipoprotein
antigen speciﬁcally expressed by all strains of H. pylori that has
been shown to act as a potential target for vaccine and pharma-
cotherapy6,7. In our laboratory, an exposed antigenic domain of
Lpp20 (amino acids 83–115 from the N-terminus, abbreviated as
NQA) was imprinted on the surface of nanoparticles. According to
research by our group8 and Zeng et al.5, “surface imprinting” is
more likely to be achieved during an inverse mini-emulsion
polymerization process when the template molecules are amphi-
philic. Based on this consideration, the hydrophilic NQA was
modiﬁed with a long hydrocarbon tail (from myristic acid (Myr))
and used as the template to imprint surface capture sites for theentire Lpp20 lipoprotein. Such an epitope imprinting strategy has
been previously used to capture Staphylococus aureus9–11.
Some reports have argued that one of the technical challenges in
molecular imprinting of proteins relates to the quantitation of the
resulting binding. In many cases, determination of the extent of
binding is unreliable and leads to unconvincing results12. There-
fore, newly designed approaches to quantitation are required. In
the current study, several approaches to assess protein–protein
interactions or the bioadhesive properties of polymers including
surface plasmon resonance (SPR), ﬂuorescence polarization (FP)
and changes in zeta potential were applied to evaluate the binding
of the template to the MIPs. Preliminary in vitro studies were also
performed to evaluate the efﬁcacy of the MIPs to speciﬁcally
adhere to H. pylori. Further studies on therapeutic drug delivery by
means of this type of SMINs are underway.2. Materials and methods
2.1. Materials
Acrylamide, N,N′-methylenebisacrylamide (BisAM), ammonium
persulfate (APS) and N,N,N′,N′-tetramethylethylenediamine
(TEMED) were purchased from Aladdin Reagents Co., Ltd.
(Shanghai). 5-Carboxyﬂuoresccein (FAM) and dioctyl sulfosucci-
nate sodium salt (AOT) were purchased from Sigma-Aldrich. Brij
30 was supplied by J&K Chemicals. NQA (MW 3582 Da, pI 9.5),
myristic acid modiﬁed NQA (Myr-NQA), and FAM modiﬁed
NQA (FAM-NQA) were obtained from GL Biochem. The Biacore
sensor chip CM5 and HBS-EP buffer were purchased from GE
Healthcare. All other chemicals and solvents were analytical grade
and used as received. Deionized water was produced by a Milli-Q
integral water puriﬁcation system (Millipore).
2.2. Cell lines and H. pylori strain
Human gastric epithelial (AGS) cells were obtained from the
Institute of Biochemistry and Cell Biology, Shanghai Institute for
Biological Sciences, Chinese Academy of Sciences. Cells were
maintained in Ham's F-12 medium (GIBCO BRL, Grand Island,
NY, USA) containing 10% fetal calf serum and cultured in
incubators maintaining 5% CO2 under microaerophilic conditions
at 37 1C. H. pylori strain SS1 was obtained from the Institute of
Gastrointestinal Disease, Yan Chai Hospital.
2.3. Preparation of nanoparticles
Myr-NQA imprinted nanoparticles (Myr-NQA-MINs) were pre-
pared as previously reported with some modiﬁcations5. Brieﬂy, a
monomer solution was formed by dissolving acrylamide (0.45 g)
and BisAM (0.13 g) in 1.0 mL water. Myr-NQA (8.0 mg) was
added to the solution and magnetically stirred to facilitate effective
monomer-template interaction. Subsequently, 1.0 mL of this
monomer-template solution was added dropwise to a deoxyge-
nated mixture of hexane (21.5 mL), AOT (0.70 g) and Brij 30
(1.50 g), and stirred continuously for 30 min. Finally, APS
solution (10% w/v, 50 μL) followed by TEMED (25 μL) were
added to the mixture to initiate polymerization. The reaction was
allowed to proceed at room temperature for 2 h after which
nanoparticles were precipitated and washed 4 times with excess
ethanol to remove unreacted monomer, template and surfactant.
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gel chromatography (G50). Puriﬁed nanoparticles were lyophilized
and kept at room temperature until further characterization. NQA
imprinted nanoparticles (NQA-MINs) and non-imprinted nanopar-
ticles (NINs) were prepared in the same way using NQA as
template in the former and no template in the latter.
2.4. Particle size and morphology
Size and zeta potential of nanoparticles were measured using a
Malvern Zetasizers Nano ZS90 (Malvern Instruments, UK).
Nanoparticles were suspended in deionized water at a concentra-
tion of 2 mg/mL and sonicated prior to measurement. Nanoparticle
morphology was examined by transmission electron microscopy
(TEM) (JEM-2100 F, JEOL, Japan) and dynamic light scattering
(DLS).
2.5. Template nanoparticle interaction
2.5.1. SPR analysis
Template-nanoparticle interaction was investigated using a Biacore
X100 instrument (GE Healthcare, USA). NQA was immobilized
on a CM5 sensor chip according to the manufacturer's instructions.
Suspensions of nanoparticles were ﬁltered through 0.22 μm
syringe ﬁlters and diluted in HBS-EP buffer (GE Healthcare,
USA) to give a three-fold concentration series (0.25, 0.74, 2.22,
6.67 and 20 mg/mL). The freshly prepared suspensions were then
allowed to ﬂow over the NQA sensor chip according to a so-called
“kinetic titration” procedure using HBS-EP as running buffer13,14.
For each injection, nanoparticle suspensions ﬂowed over the
sensor chip at 20 μL/min at 25 1C for 3 min. An unmodiﬁed
sensor chip served as a reference to correct for instrumental noise
and drift.
2.5.2. Change in zeta potential
Analysis of zeta potential was based on the “mucin particle method”
previously used to study the mucoadhesion of polymers to commer-
cially available mucin particles15. Brieﬂy, to nanoparticle suspensions
in water (4 mg/mL), NQA was added to give a ﬁnal concentration of
75 μg/mL and incubated overnight. Since NQA is positively charged
at pH 7.0 (pI 9.5), it was assumed that the zeta potential of
nanoparticles would increase due to adsorption of template. Zeta
potential of nanoparticles was monitored using a Malvern Zetasizers
Nano Series DTS 1060 (Malvern Instruments, UK).
2.5.3. Fluorescence polarization (FP) studies
The application of FP is based on the assumption that binding of
the ﬂuorescence-labeled molecule to nanoparticles decreases its
molecular rotation in solution which can be detected by FP. NQA
was N-terminally labeled with FAM and puriﬁed. Then a constant
amount of FAM-labeled peptide (about 20 nmol/L) was incubated
with suspensions of nanoparticles in water at a range of concen-
trations. FP was measured using a Tecan M1000 microplate reader
(Tecan, Swiss), and values corrected by subtracting the value
corresponding to the labeled peptide in water.
2.6. In vitro interaction between nanoparticles and H. pylori
2.6.1. Flow cytometry studies
A BD FACSCalibur ﬂuorescence-activated ﬂow cytometer (BD,
USA) was used to investigate the interaction betweennanoparticles and H. pylori. FAM-loaded nanoparticles (FAM-
Myr-NQA-MINs, FAM-NQA-MINs and FAM-NINs) were pre-
pared by adding FAM during their preparation. FAM-loaded
nanoparticles were separated from free FAM by gel chromato-
graphy and lyophilized. Examination by ﬂuorescence spectrometry
showed that all nanoparticles displayed similar ﬂuorescence
intensity. The standard microbial strain of H. pylori (Sydney
Strain SS1) was cultivated for two days microaerophilically at
37 1C on solid medium. The bacteria were then suspended in
physiological saline and nutrient medium, respectively, incubated
with 2 mg/mL FAM-loaded nanoparticles for 2 h and ﬁxed with
2.5% glutaraldehyde. Finally samples were centrifuged, rinsed and
subjected to ﬂow cytometric analysis. For each measurement,
1 104 and 2 104 bacteria were counted to determine the
number giving a positive signal in the FL-1 channel.
2.6.2. Studies using the SS1-AGS model
A ﬂuorescence microscope was used to observe the in vitro
interaction between nanoparticles and SS1 H. pylori adsorbed on
AGS cells. This was based on the premise that the SS1-AGS
model mimics the adhesion of H. pylori to gastric epithelial cells
in vivo. SS1 bacteria were microaerophilically cultivated for 48 h
at 37 1C on solid medium and then suspended in F12 medium at
about 1.0 108 cells/mL. AGS cells were cultivated in a 24-well
plate for 48 h after which 0.3 mL bacteria suspension was added
into each well and incubated for 1 h before washing 3 times with
saline. Then aliquots (0.3 mL) of suspensions (2 mg/mL) of FAM-
loaded nanoparticles were added into each well and incubated with
either AGS cells or the SS1-AGS model for 2 h. Finally samples
were examined by ﬂuorescence microscopy.
2.7. Statistical analysis
Statistical comparison between samples was evaluated by Student's
t-tests performed using Microsoft Excel.3. Results and discussion
3.1. Synthesis of SMINs
Subsequent to the conventional bulk polymerization method in
which template molecules are embedded within the bulk of the
polymer matrix, some novel approaches such as mini-emulsion
polymerization and precipitation polymerization have recently
been introduced to prepare micro- and nano-structured protein
imprinted polymers16–18. Compared to the conventional approach,
the products of these newer techniques possess higher adsorption
capacity due to their increased surface area. However, they are still
deﬁcient, because protein molecules are mostly hydrophilic and
randomly distributed in the aqueous monomer solution, the
majority of protein is restricted in the polymeric matrix and
inaccessible to the template. To solve this problem, we employed
inverse microemulsion polymerization as proposed by Zeng et al.5
and modiﬁed the hydrophilic NQA with the long-chain fatty acid,
myristic acid, to form an amphiphilic molecule. During the
emulsion process, the amphiphilic template functions as a surfac-
tant and arranges itself at the oil-water interface with its hydro-
philic head protruding into the aqueous phase and its hydrophobic
tail oriented outwards. This was anticipated to promote interaction
between the hydrophilic peptide and the monomer and also create
imprints directly at or near the surface of the nanoparticles. The
Table 1 Summary information of the sizes of NINs, NQA-
MINs and Myr-NQA-MINs.
Sample Mean diameter (nm) PDI
NINs 30.4 0.126
NQA-MINs 28.5 0.155
Myr-NQA-MINs 27.9 0.200
NINs, non-imprinted nanoparticles; NQA-MINs, NQA imprinted
nanoparticles; Myr-NQA-MINs, myristic acid modiﬁed NQA
imprinted nanoparticles; PDI, particle distribution index.
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found in the natural immune response where only the surface
epitope part of a macromolecule is recognized by the antibody2.
The preparation procedure is summarized in Scheme 1.
3.2. Particle size and morphology
A TEM micrograph showing the morphology of Myr-NQA-MINs
is shown in Fig. 1. The nanoparticles are seen to be regularly
shaped and highly monodispersed. DLS studies (Table 1) show
that nanoparticles were about 30 nm in diameter and display
similar values of particle distribution index (PDI) despite the
addition of template peptide during preparation.
3.3. SPR studies
Interaction between immobilized NQA and nanoparticles as studied by
SPR is shown in Fig. 2. It was found that injection of Myr-NQA-MINs
resulted in a marked concentration-dependent increase in response
values (RU). Thus injection of suspensions with the three higher
concentrations (2.22, 6.67 and 20 mg/mL) led to particularly high
levels of RU whereas signals for nanoparticle suspensions with lower
concentrations were less signiﬁcant. This indicates that, at higher
concentrations, the presence of a large number of high-afﬁnity binding
sites on the surface of Myr-NQA-MINs offers more opportunity for
rapid adsorption of template molecules. NQA-MINs did not seem toScheme 1 Schematic representation of the preparation of surface
molecularly imprinted nanoparticles.
Figure 1 Micrograph of Myr-NQA-MINs obtained by transmission
electron microscopy. The scale bars represents 100 nm.
Figure 2 Sensorgrams of time-dependent binding of Myr-NQA-
MINs, NQA-MINs and NINs to template peptide immobilized on an
SPR chip. The corresponding concentrations of nanoparticles are 0,
0.25, 0.74, 2.22, 6.67 and 20 mg/mL.interact strongly with immobilized template at any concentration and
its sensorgram was quite similar to that of NINs. This was probably
because the absence of surface imprints prevented them from
effectively interacting with the template molecules. These results
indicate the successful fabrication of speciﬁcally imprinted cavities
on the surface of Myr-NQA-MINs.
Interestingly, no dissociation of bound nanoparticles was observed
at any concentration after the association process. This is consistent
with the ﬁndings of Verheyen et al.12 who concluded that the absence
of dissociation was due to a very strong interaction between SMINs
and template. However, we maintain that, besides the interaction, the
phenomenon could also be partly due to sedimentation of nanoparticles
onto the sensor chip leading to a “strong binding” artifact. Because of
this, we employed a “kinetic titration” approach characterized by sequ-
entially injecting an increasing concentration of nanoparticles with no
regeneration step13,14.
3.4. Change in zeta potential
According to the “mucin particle method”, the surface of mucin
particles is changed by adhesion of mucoadhesive polymer giving rise
to a change in zeta potential of the particles15. Changes resulting from
the interaction between templates and nanoparticles are shown in
Fig. 3. For NINs, NQA-MINs and Myr-NQA-MINs, zeta potential
increased by 2.86, 2.88 and 5.22 mV respectively. This was as
expected given that surface imprinted Myr-NQA-MINs probably
display a higher afﬁnity toward NQA than its counterparts. For NINs
and NQA-MINs, the increase in zeta potential is probably due to
nonspeciﬁc adsorption of template peptide.
Figure 3 (a) Zeta potential of NINs, NQA-MINs and Myr-NQA-MINs before (white) and after (black) incubation with NQA for 12 h and (b) the
zeta potential differences (*Po0.01, Student's t-test).
Scheme 2 Illustration of the principle of ﬂuorescence polarization as
applied to study the interaction between template and nanoparticles.
Figure 4 Fluorescence polarization of FAM-labeled NQA (20 nmol/
L) after incubation with nanoparticles suspensions with different
concentrations (*Po0.01, **Po0.005, Student's t-test). NPs,
nanoparticles.
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FP is a versatile solution-based technique that has long been
employed to study protein–protein interactions. The principle of
FP derives from the fact that the degree of polarization of a
ﬂuorophore (in this case FAM) is inversely related to its
molecular rotation as indicated in Scheme 219. As shown in
Fig. 4, at low concentrations of nanoparticles (0.78 and
1.56 μg/mL), FP of Myr-NQA-MINs after incubation with
FAM labeled template was signiﬁcantly higher than FP of
NQA-MINs and NINs. This can be attributed to the higher
afﬁnity of Myr-NQA-MINs for template molecules. However, at
higher concentrations of nanoparticles (100 and 200 μg/mL),
there were no signiﬁcant differences in FP of the three types of
nanoparticles. This is presumably because in all cases the
majority of template molecules are adsorbed onto the nanopar-
ticles due to both speciﬁc and nonspeciﬁc interactions and the
greater afﬁnity of Myr-NQA-MINs for template is masked.Figure 5 Speciﬁc binding of various nanoparticles to the Sydney
Strain of H. pylori (SS1) detected by ﬂow cytometry (*Po0.01,
Student's t-test).3.6. H. pylori adhesion studies
3.6.1. Cytometric analysis
The ability of the three types of nanoparticles to adhere to H. pylori is
compared in Fig. 5. Binding of NINs to H. pylori still occurred
presumably due to non-speciﬁc adsorption. Adsorption of Myr-NQA-
MINs was the highest but adsorption of NQA-MINs was somewhat
inconsistent being higher than that of NINs for some groups but less
for others. We hypothesize this reﬂects inconsistent imprinting of the
surface of NQA-MINs due to the hydrophilic quality of NQA
or that the sites created do not matchthe NQA on the SS1 H. pylori
bacteria.3.6.2. Fluorescence microscopy studies
Both FAM-Myr-NQA-MINs and FAM-NINs were adsorbed onto
AGS cells but the surface ﬂuorescence intensity on AGS cells was
much lower than that on the SS1-AGS model (Fig. 6). FAM-Myr-
NQA-MINs were adsorbed more on H. pylori as indicated by the
higher ﬂuorescence intensity on the bacteria. On the other hand,
FAM-NINs were scattered more randomly on the surface of the
AGS cells. We infer this is because Myr-NQA-MINs are
Figure 6 Representative ﬂuorescent photomicrographs of binding of various nanoparticles to SS1-AGS model. The concentration of
nanoparticles is 2 mg/mL. The scale bars represents 200 μm.
Jiaying Han et al.582recognized by the surface lipoprotein of H. pylori and are more
speciﬁcally absorbed while NINs are probably adsorbed non-
speciﬁcally onto AGS cells.4. Conclusions
In the present study, we prepared a novel peptide imprinted
nanoparticle for speciﬁc H. pylori adhesion. We used the general
strategy of surface imprinting with an epitope imprinting approach.
Studies of the interaction between template peptide and nanopar-
ticles based on SPR, change in zeta potential and FP indicated that
Myr-NQA-MINs possess speciﬁc recognition sites for the template
compared to NQA-MINs and NINs. A preliminary in vitro study
of the ability of these surface molecularly imprinted nanoparticles
to adhere to H. pylori was sufﬁciently positive to encourage us to
further explore the therapeutic potential of this kind of nanopar-
ticle for H. pylori eradication.
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